The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.
about
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyMining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data.CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.Immuno-therapy with anti-CTLA4 antibodies in tolerized and non-tolerized mouse tumor models.Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cellsControlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumabNatural history of tumor growth and immune modulation in common spontaneous murine mammary tumor modelsTherapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptTLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerCoordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell ActivityA new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses.The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent.Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells.Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvantToward a stem cell gene therapy for breast cancer.Sequential model selection-based segmentation to detect DNA copy number variation.EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer.Prospects for new lung cancer treatments that target EMT signaling.TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays
P2860
Q30436422-36EF97EB-2AA8-40CF-A7DA-C3D98E1D0BC7Q30438965-DE1F92A9-551A-4428-B7D3-CB5D9EA50CD5Q33618065-2D3205C2-6875-428E-ABF0-AD2E758D8C36Q33662452-7C9510DA-7EFB-4F66-95ED-632929298D28Q33726546-E09C07FE-7C12-416D-8BA6-CF476B56596CQ33846310-64AA49E7-C499-4547-9D10-E160CA909FA0Q33894643-2EA62541-2D3A-4694-83A8-0C6A3A4F0D1EQ33968361-46427CDE-2B95-42B7-B18D-F35D0D1EBB11Q34149109-87842CF8-CB46-4710-875F-37EB82FB2C4BQ34621713-C3DA9EE2-DC3B-49BA-9820-8E67139AF512Q34789746-4FE90C58-26A3-40C1-846B-8C6A3028DB30Q35193892-AFB80BBA-0767-4EF4-8F14-9D297D070BB0Q35510560-7C9642AB-0BEC-4F70-9D16-29E8A7772A5AQ35551792-BB69770C-0905-4EBE-9569-666C4E6DA426Q35623804-E1CAEB77-1646-41D4-A656-8EB9F02D6D2AQ35940189-6AF632BC-F873-4E06-A41E-A84F49235392Q36023115-D80A4D90-657C-4EA4-82B3-359E19859DEFQ36863278-7E0D1101-D628-4FFE-B6C0-B82D17CC818AQ36875990-803A2FBD-8575-417B-B320-4BE52F72DD1EQ37001399-B387B8CA-A419-4824-AC29-4C05FE7C1A87Q37056096-B84FAC3D-F6E5-4D57-961F-6AEEC97ABB56Q37198471-58215066-FD12-4A2A-B391-88D35E660967Q37209024-3F3BE26A-1B7A-4F8F-95FB-2A65DB6BF61BQ37248153-43B7D085-D5B0-4F45-A4F2-38F3F7B5B7ABQ37688408-FEB4CEEF-5E41-4203-927B-5C790E3AF3E8Q40018639-5AF7D16E-8DD7-4E0E-A7F7-8FF9BCF01F7CQ41409074-EBD73B4A-ECD2-4EF2-8D6F-74AB79F598F2Q48271468-F57DC935-1613-4A02-B609-12D83953445CQ49977478-7D15994E-04F3-411C-B234-C6FD56481012Q57143261-DD70D7AE-6538-4D89-B023-48C021C6155E
P2860
The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The tumor antigen repertoire i ...... predicts human tumor antigens.
@ast
The tumor antigen repertoire i ...... predicts human tumor antigens.
@en
The tumor antigen repertoire i ...... predicts human tumor antigens.
@nl
type
label
The tumor antigen repertoire i ...... predicts human tumor antigens.
@ast
The tumor antigen repertoire i ...... predicts human tumor antigens.
@en
The tumor antigen repertoire i ...... predicts human tumor antigens.
@nl
prefLabel
The tumor antigen repertoire i ...... predicts human tumor antigens.
@ast
The tumor antigen repertoire i ...... predicts human tumor antigens.
@en
The tumor antigen repertoire i ...... predicts human tumor antigens.
@nl
P2093
P1433
P1476
The tumor antigen repertoire i ...... predicts human tumor antigens.
@en
P2093
Hailing Lu
Keith L Knutson
Mary L Disis
P304
P356
10.1158/0008-5472.CAN-06-1083
P407
P577
2006-10-01T00:00:00Z